Evaluation of the BioFire® FilmArray® Pneumonia plus Panel for Detecting Bacterial Etiological Agents of Lower Respiratory Tract Infections in an Oncologic Hospital. Comparison with Conventional Culture Method
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Alnimr A. Antimicrobial resistance in ventilator-associated pneumonia: Predictive microbiology and evidence-based therapy. Infect Dis Ther. 2023 Jun;12(6):1527–1552. https://doi.org/10.1007/s40121-023-00820-2AlnimrA.Antimicrobial resistance in ventilator-associated pneumonia: Predictive microbiology and evidence-based therapy..2023Jun;12(6):1527–1552. https://doi.org/10.1007/s40121-023-00820-2Open DOISearch in Google Scholar
Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR, van de Louw A, Hemelaar P, Lemiale V, Taccone FS, et al.; Efraim investigators and the Nine-I study group. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med. 2017 Dec; 43(12):1808–1819. https://doi.org/10.1007/s00134-017-4947-1AzoulayEPickkersPSoaresMPernerARelloJBauerPRvan de LouwAHemelaarPLemialeVTacconeFSEfraim investigators and the Nine-I study group.; .Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study..2017Dec;43(12):1808–1819. https://doi.org/10.1007/s00134-017-4947-1Open DOISearch in Google Scholar
Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, Montero JG, Loeches IM, Mehta S, Puxty K, et al; Nine-i Investigators. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020 Feb;46(2):298–314. https://doi.org/10.1007/s00134-019-05906-5AzoulayERussellLVan de LouwAMetaxaVBauerPPovoaPMonteroJGLoechesIMMehtaSPuxtyKNine-i Investigators; .Diagnosis of severe respiratory infections in immunocompromised patients..2020Feb;46(2):298–314. https://doi.org/10.1007/s00134-019-05906-5Open DOISearch in Google Scholar
Bai L, Yang W, Li Y. Clinical and laboratory diagnosis of Legionella Pneumonia. Diagnostics. 2023 Jan 12;13(2):280. https://doi.org/10.3390/diagnostics13020280BaiLYangWLiY.Clinical and laboratory diagnosis of Legionella Pneumonia..2023Jan12;13(2):280. https://doi.org/10.3390/diagnostics13020280Open DOISearch in Google Scholar
Black AD. Non-infectious mimics of community-acquired pneumonia. Pneumonia. 2016 Apr;8:2. https://doi.org/10.1186/s41479-016-0002-1BlackAD.Non-infectious mimics of community-acquired pneumonia..2016Apr;8:2. https://doi.org/10.1186/s41479-016-0002-1Open DOISearch in Google Scholar
Buchan BW, Windham S, Balada-Llasat JM, Leber A, Harrington A, Relich R, Murphy C, Dien Bard J, Naccache S, Ronen S, et al. Practical comparison of the BioFire FilmArray Pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol. 2020 Jun;58(7):e00135-20. https://doi.org/10.1128/JCM.00135-20BuchanBWWindhamSBalada-LlasatJMLeberAHarringtonARelichRMurphyCDien BardJNaccacheSRonenS.Practical comparison of the BioFire FilmArray Pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections..2020Jun;58(7):e00135-20. https://doi.org/10.1128/JCM.00135-20Open DOISearch in Google Scholar
Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. Cummitech 31A, Verification and validation of procedures in the clinical microbiology laboratory. Washington (USA): ASM Press; 2009.ClarkRBLewinskiMALoeffelholzMJTibbettsRJ..Washington (USA):ASM Press;2009.Search in Google Scholar
Conway Morris A. Management of pneumonia in intensive care. J Emerg Crit Care Med. 2018 Dec;2:10. https://doi.org/10.21037/jeccm.2018.11.06Conway MorrisA.Management of pneumonia in intensive care..2018Dec;2:10. https://doi.org/10.21037/jeccm.2018.11.06Open DOISearch in Google Scholar
Cristovam E, Almeida D, Caldeira D, Ferreira JJ, Marques T. Accuracy of diagnostic tests for Legionnaires’ disease: A systematic review. J Med Microbiol. 2017 Apr;66(4):485–489. https://doi.org/10.1099/jmm.0.000454CristovamEAlmeidaDCaldeiraDFerreiraJJMarquesT.Accuracy of diagnostic tests for Legionnaires’ disease: A systematic review..2017Apr;66(4):485–489. https://doi.org/10.1099/jmm.0.000454Open DOISearch in Google Scholar
Edin A, Eilers H, Allard A. Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections. Infect Dis. 2020 Jul;52(7):479–488. https://doi.org/10.1080/23744235.2020.1755053EdinAEilersHAllardA.Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections..2020Jul;52(7):479–488. https://doi.org/10.1080/23744235.2020.1755053Open DOISearch in Google Scholar
EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Antimicrobial susceptibility testing EUCAST disk diffusion method. Version 11.0. Stockholm (Sweden): The European Committee on Antimicrobial Susceptibility Testing; 2023a [cited 2023 Mar 29]. Available from https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodologyEUCAST.. Version 11.0.Stockholm (Sweden):The European Committee on Antimicrobial Susceptibility Testing;2023a[cited 2023 Mar 29].Available from https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodologySearch in Google Scholar
EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0. Stockholm (Sweden): The European Committee on Antimicrobial Susceptibility Testing; 2023b [cited 2023 Mar 29]. Available from: https://www.eucast.org/clinical_breakpointsEUCAST.The European Committee on Antimicrobial Susceptibility Testing.. Version 13.0.Stockholm (Sweden):The European Committee on Antimicrobial Susceptibility Testing;2023b[cited 2023 Mar 29].Available from: https://www.eucast.org/clinical_breakpointsSearch in Google Scholar
Fernández-Cruz A, Ortega L, García G, Gallego I, Álvarez-Uría A, Chamorro-de-Vega E, García-López JJ, González-Del-Val R, Martín-Rabadán P, Rodríguez C, et al. Etiology and prognosis of pneumonia in patients with solid tumors: A prospective cohort of hospitalized cases. Oncologist. 2020 May;25(5):e861-e869 https://doi.org/10.1634/theoncologist.2019-0031Fernández-CruzAOrtegaLGarcíaGGallegoIÁlvarez-UríaAChamorro-de-VegaEGarcía-LópezJJGonzález-Del-ValRMartín-RabadánPRodríguezC.Etiology and prognosis of pneumonia in patients with solid tumors: A prospective cohort of hospitalized cases..2020May;25(5):e861-e869 https://doi.org/10.1634/theoncologist.2019-0031Open DOISearch in Google Scholar
Ginocchio CC, Garcia-Mondragon C, Mauerhofer B, Rindlisbacher C; and the EME Evaluation Program Collaborative. Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing. Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1609–1622. https://doi.org/10.1007/s10096-021-04195-5GinocchioCCGarcia-MondragonCMauerhoferBRindlisbacherCand the EME Evaluation Program Collaborative.Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing..2021Aug;40(8):1609–1622. https://doi.org/10.1007/s10096-021-04195-5Open DOISearch in Google Scholar
Han XY, Ihegword A, Evans SE, Zhang J, Li L, Cao H, Tarrand JJ, El-Kweifi O. Microbiological and clinical studies of legionellosis in 33 patients with cancer. J Clin Microbiol. 2015 Jul;53(7):2180–2187. https://doi.org/10.1128/JCM.00380-15HanXYIhegwordAEvansSEZhangJLiLCaoHTarrandJJEl-KweifiO.Microbiological and clinical studies of legionellosis in 33 patients with cancer..2015Jul;53(7):2180–2187. https://doi.org/10.1128/JCM.00380-15Open DOISearch in Google Scholar
Hryniewicz W, Albrecht P, Radzikowski A. [Rekomendacje postq-powania w pozaszpitalnych zakazeniach ukladu oddechowego] (in Polish). Warsaw (Poland): Narodowy Instytut Leków; 2016.HryniewiczWAlbrechtPRadzikowskiA..Warsaw (Poland):Narodowy Instytut Leków;2016.Search in Google Scholar
ICNARC. Intensive Care National Audit and Research Centre. Key statistics from the Case Mix Programme - adult, general critical care units. 1 April 2015 to 31 March 2016. London (UK): Intensive Care National Audit and Research Centre; 2017 [cited 2023 Apr 12]. Available from: http://www.icnarc.orgICNARC..London (UK):Intensive Care National Audit and Research Centre;2017[cited 2023 Apr 12].Available from: http://www.icnarc.orgSearch in Google Scholar
Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al.; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015 Jul;373(5):415–427. https://doi.org/10.1056/NEJMoa1500245JainSSelfWHWunderinkRGFakhranSBalkRBramleyAMReedCGrijalvaCGAndersonEJCourtneyDMCDC EPIC Study Team.Community-acquired pneumonia requiring hospitalization among U.S. adults..2015Jul;373(5):415–427. https://doi.org/10.1056/NEJMoa1500245Open DOISearch in Google Scholar
Jitmuang A, Puttinad S, Hemvimol S, Pansasiri S, Horthongkham N. A multiplex pneumonia panel for diagnosis of hospital-acquired and ventilator-associated pneumonia in the era of emerging antimicrobial resistance. Front Cell Infect Microbiol. 2022 Oct;12:77320. https://doi.org/10.3389/fcimb.2022.977320JitmuangAPuttinadSHemvimolSPansasiriSHorthongkhamN.A multiplex pneumonia panel for diagnosis of hospital-acquired and ventilator-associated pneumonia in the era of emerging antimicrobial resistance..2022Oct;12:77320. https://doi.org/10.3389/fcimb.2022.977320Open DOISearch in Google Scholar
Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG, Carratalà J, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016 Sep;63(5):e61-e111. https://doi.org/10.1093/cid/ciw353KalilACMeterskyMLKlompasMMuscedereJSweeneyDAPalmerLBNapolitanoLMO’GradyNPBartlettJGCarratalàJ.Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society..2016Sep;63(5):e61-e111. https://doi.org/10.1093/cid/ciw353Open DOISearch in Google Scholar
Kamel NA, Alshahrani MY, Aboshanab KM, El Borhamy MI. Evaluation of the BioFire FilmArray Pneumonia Panel Plus to the conventional diagnostic methods in determining the microbiological etiology of hospital-acquired pneumonia. Biology. 2022 Feb;11(3):377. https://doi.org/10.3390/biology11030377KamelNAAlshahraniMYAboshanabKMEl BorhamyMI.Evaluation of the BioFire FilmArray Pneumonia Panel Plus to the conventional diagnostic methods in determining the microbiological etiology of hospital-acquired pneumonia..2022Feb;11(3):377. https://doi.org/10.3390/biology11030377Open DOISearch in Google Scholar
Kumar ST, Yassin A, Bhowmick T, Dixit D. Recommendations from the 2016 guidelines for the management of adults with hospital-acquired or ventilator-associated pneumonia. PT. 2017 Dec; 42(12):767–772.KumarSTYassinABhowmickTDixitD.Recommendations from the 2016 guidelines for the management of adults with hospital-acquired or ventilator-associated pneumonia..2017Dec;42(12):767–772.Search in Google Scholar
Leoni D, Encina B, Rello J. Managing the oncologic patient with suspected pneumonia in the intensive care unit. Expert Rev Anti Infect Ther. 2016 Oct;14(10):943–960. https://doi.org/10.1080/14787210.2016.1228453LeoniDEncinaBRelloJ.Managing the oncologic patient with suspected pneumonia in the intensive care unit..2016Oct;14(10):943–960. https://doi.org/10.1080/14787210.2016.1228453Open DOISearch in Google Scholar
Latgé JP, Chamilos G.Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev. 2019 Nov;33(1):e00140-18. https://doi.org/10.1128/CMR.00140-18LatgéJPChamilosG.Aspergillus fumigatus and aspergillosis in 2019..2019Nov;33(1):e00140-18. https://doi.org/10.1128/CMR.00140-18Open DOISearch in Google Scholar
Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, Akerele O, Buchan B, Windham S, Hopp A, Ronen S, et al. Multicenter evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol. 2020 Jun;58(7):e00128-20. https://doi.org/10.1128/JCM.00128-20MurphyCNFowlerRBalada-LlasatJMCarrollAStoneHAkereleOBuchanBWindhamSHoppARonenS.Multicenter evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection..2020Jun;58(7):e00128-20. https://doi.org/10.1128/JCM.00128-20Open DOISearch in Google Scholar
Murphy T, Schwedock J, Nguyen K, Mills A, Jones D. Evaluation of PDA Technical Report No 33. Statistical testing recommendations for a rapid microbiological method case study. PDA J Pharm Sci Technol. 2015 Jul-Aug;69(4):526–539. https://doi.org/10.5731/pdajpst.2015.01062MurphyTSchwedockJNguyenKMillsAJonesD.Evaluation of PDA Technical Report No 33. Statistical testing recommendations for a rapid microbiological method case study..2015Jul-Aug;69(4):526–539. https://doi.org/10.5731/pdajpst.2015.01062Open DOISearch in Google Scholar
Nauclér P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, Tangdén T. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. 2021 Feb;27(2):175–181. https://doi.org/10.1016/j.cmi.2020.02.032NauclérPHuttnerAvan WerkhovenCHSingerMTattevinPEinavSTangdénT.Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship..2021Feb;27(2):175–181. https://doi.org/10.1016/j.cmi.2020.02.032Open DOISearch in Google Scholar
PDA. Evaluation, validation and implementation of new microbiological testing methods. Technical Report No. 33. Bethesda (USA): Parenteral Drug Association; 2000.PDA.. Technical Report No. 33.Bethesda (USA):Parenteral Drug Association;2000.Search in Google Scholar
Parody R, Rabella N, Martino R, Otegui M, del Cuerpo M, Coll P, Sierra J. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol. 2007 Sep;82(9):807–811. https://doi.org/10.1002/ajh.20974ParodyRRabellaNMartinoROteguiMdel CuerpoMCollPSierraJ.Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies..2007Sep;82(9):807–811. https://doi.org/10.1002/ajh.20974Open DOISearch in Google Scholar
Ren J, Kang JB, Ma YP, Zhang JH, Dong CX, Kang JM, Zhang RJ, Wang MF, Ge XY, Yang LH. [Pathogen distribution and antimicrobial resistance among lower respiratory tract infections in patients with hematological malignancies] (in Chinese). Zhonghua Nei Ke Za Zhi. 2021 Oct 1;60(10):875–879. https://doi.org/10.3760/cmaj.cn112138-20201228-01056RenJKangJBMaYPZhangJHDongCXKangJMZhangRJWangMFGeXYYangLH.[Pathogen distribution and antimicrobial resistance among lower respiratory tract infections in patients with hematological malignancies] (in Chinese)..2021Oct1;60(10):875–879. https://doi.org/10.3760/cmaj.cn112138-20201228-01056Open DOISearch in Google Scholar
Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lacta-mase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018 Feb;31(2):e00079-17. https://doi.org/10.1128/CMR.00079-17Rodríguez-BañoJGutiérrez-GutiérrezBMachucaIPascualA.Treatment of infections caused by extended-spectrum-beta-lacta-mase-, AmpC-, and carbapenemase-producing Enterobacteriaceae..2018Feb;31(2):e00079-17. https://doi.org/10.1128/CMR.00079-17Open DOISearch in Google Scholar
Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001 Jul;13(4):218–223. https://doi.org/10.1097/00001622-200107000-00002RolstonKV.The spectrum of pulmonary infections in cancer patients..2001Jul;13(4):218–223. https://doi.org/10.1097/00001622-200107000-00002Open DOISearch in Google Scholar
Rolston KV. Infections in cancer patients with solid tumors: A review. Infect Dis Ther. 2017 Mar;6(1):69–83. https://doi.org/10.1007/s40121-017-0146-1RolstonKV.Infections in cancer patients with solid tumors: A review..2017Mar;6(1):69–83. https://doi.org/10.1007/s40121-017-0146-1Open DOISearch in Google Scholar
Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, Asehnoune K. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med. 2019 Aug;7(8):710–720. https://doi.org/10.1016/S2213-2600(19)30140-7RoquillyATorresAVilladangosJANeteaMGDicksonRBecherBAsehnouneK.Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia..2019Aug;7(8):710–720. https://doi.org/10.1016/S2213-2600(19)30140-7Open DOISearch in Google Scholar
Schmiedel Y, Zimmerli S. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly. 2016 Feb;146:w14281. https://doi.org/10.4414/smw.2016.14281SchmiedelYZimmerliS.Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia..2016Feb;146:w14281. https://doi.org/10.4414/smw.2016.14281Open DOISearch in Google Scholar
Tabatabai J, Schnitzler P, Prifert C, Schiller M, Weissbrich B, von Lilienfeld-Toal M, Teschner D, Jordan K, Müller-Tidow C, Egerer G, et al. Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding. PLoS One. 2022 Jul;17(7):e0271756. https://doi.org/10.1371/journal.pone.0271756TabatabaiJSchnitzlerPPrifertCSchillerMWeissbrichBvon Lilienfeld-ToalMTeschnerDJordanKMüller-TidowCEgererG.Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding..2022Jul;17(7):e0271756. https://doi.org/10.1371/journal.pone.0271756Open DOISearch in Google Scholar
Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016 Dec;48(6):1764–1778. https://doi.org/10.1183/13993003.01144-2016TorresALeeNCillonizCVilaJVan der EerdenM.Laboratory diagnosis of pneumonia in the molecular age..2016Dec;48(6):1764–1778. https://doi.org/10.1183/13993003.01144-2016Open DOISearch in Google Scholar
Watkins RR. Using precision medicine for the diagnosis and treatment of viral pneumonia. Adv Ther. 2022 Jul;39(7):3061–3071. https://doi.org/10.1007/s12325-022-02180-8WatkinsRR.Using precision medicine for the diagnosis and treatment of viral pneumonia..2022Jul;39(7):3061–3071. https://doi.org/10.1007/s12325-022-02180-8Open DOISearch in Google Scholar
Wong JL, Evans SE. Bacterial pneumonia in patients with cancer: Novel risk factors and management. Clin Chest Med. 2017 Jun; 38(2):263–277. https://doi.org/10.1016/j.ccm.2016.12.005WongJLEvansSE.Bacterial pneumonia in patients with cancer: Novel risk factors and management..2017Jun;38(2):263–277. https://doi.org/10.1016/j.ccm.2016.12.005Open DOISearch in Google Scholar